After the new coronavirus variant omicron , which has created a kind of ‘panic’ atmosphere all over the world for the last few days, has been on the agenda, the effectiveness of vaccines on this new variant has also started to be discussed. The company, which produces the coronavirus vaccine, has started working to determine how effective the vaccines are on the omicron.
BioNTech CEO Uğur Şahin, who is one of the important names in this regard, told the US-based The Wall Street Journal (WSJ) newspaper, that those who are worried about the new variant “stay calm “.
A new vaccine may not need to be developed:
BioNTech continues to investigate the effects of the mRNA vaccine developed and currently being applied on omicron. Şahin said, ” We have a plan to give people a third dose, and we must adhere to this plan and accelerate it. Whether we will need extra protection with an adapted vaccine will be seen later “.
Şahin also stated that omricon variant may affect vaccinated people more than other varyandollars , but the protection effect of the vaccine will continue at the point of preventing the disease from being severe. In order to learn the exact effects of the BioNTech vaccine against the variant, we will have to wait for the results of the ongoing studies.
0 Comments